Schizophrenia Disorder Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Schizophrenia Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Not Applicable

Brain Stimulation to the Hippocampus in Schizophrenia

Schizophrenia DisordersMental DisorderPsychotic Disorder
Stanford University60 enrolled1 locationNCT07010614
Recruiting
Not Applicable

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

AggressionSchizophrenia DisorderSchizoaffecitve Disorder
Manhattan Psychiatric Center58 enrolled2 locationsNCT07434479
Recruiting
Not Applicable

White Matter Plasticity in Schizophrenia

Schizophrenia Disorders
University of Maryland, Baltimore36 enrolled2 locationsNCT06641297
Recruiting
Not Applicable

Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

Schizophrenia Disorders
King's College London30 enrolled3 locationsNCT06957808
Recruiting
Phase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

SchizophreniaAlcoholismSchizophrenia Disorders+5 more
Anders Fink-Jensen, MD, DMSci108 enrolled2 locationsNCT06939088
Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Schizophrenia DisordersPersonality DisordersDepression Disorders+1 more
University of Edinburgh100 enrolled1 locationNCT07398365
Recruiting
Not Applicable

Inter-Brain Synchrony in Schizophrenia

Schizophrenia Disorder
University of California, Los Angeles100 enrolled1 locationNCT07177261
Recruiting
Not Applicable

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

Schizophrenia DisordersSchizoaffective DisorderPsychotic Disorder
University of California, San Diego201 enrolled3 locationsNCT07098169
Recruiting

KetoBrain: Brain Energy Metabolism in Schizophrenia

Schizophrenia Disorder
Ole Köhler-Forsberg34 enrolled1 locationNCT07309172
Recruiting
Phase 1

The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

Schizophrenia Disorders
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.56 enrolled1 locationNCT06674694
Recruiting
Not Applicable

Visual Perception in Schizophrenia

Schizophrenia DisordersBipolar DisorderSchizo Affective Disorder
University of Rochester84 enrolled1 locationNCT06911931
Recruiting

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

DementiaSchizophrenia DisordersBipolar Disorder (BD)+1 more
Akrivia Health50,000 enrolled1 locationNCT06641726
Recruiting
Not Applicable

Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls

Schizophrenia Disorders
University of Alabama at Birmingham200 enrolled1 locationNCT06911723
Recruiting
Not Applicable

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Schizophrenia DisordersTreatment Resistant Hallucinations
Fundació Sant Joan de Déu30 enrolled1 locationNCT07091344
Recruiting
Not Applicable

Recovery in Telling Life Stories

Eating DisordersAnxiety DisordersObsessive-Compulsive Disorder+7 more
University of Aarhus20 enrolled1 locationNCT07082777
Recruiting

HYEEG Discourse in Psychosis: A Neurobehavioural Study

Schizophrenia DisordersPsychosis
Douglas Mental Health University Institute110 enrolled1 locationNCT06978803
Recruiting
Not Applicable

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

Schizophrenia Disorders
Vanderbilt University Medical Center120 enrolled1 locationNCT06835556
Recruiting
Not Applicable

Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation

Cognitive DysfunctionSchizophrenia DisordersEmotion Regulation Disorders
Beykoz University60 enrolled1 locationNCT06936397
Recruiting

Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study

Schizophrenia DisordersParanoid Delusions
University Medical Center Groningen15 enrolled1 locationNCT06692530
Recruiting
Not Applicable

40 Hz Visual Stimulation as an Intervention in Schizophrenia

Schizophrenia DisordersSchizoaffective DisorderNegative Symptoms in Schizophrenia
Technical University of Munich20 enrolled1 locationNCT06907420